Physician profile
Henry E Aryan
NPI 1992867329
$52,080.32
in general payments reported to CMS, 2019-2025
15 companies · $23K in 2025
The $23K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $7,982 · 2021: $195 · 2023: $7,105 · 2024: $208 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $23K · Consulting Fee: $7,080 · Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $23,331.75 |
| Consulting Fee | $7,080.28 |
| Food and Beverage | $265.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $30,554.41 | 2021-2025 | |
| Precision Spine, INC. | $21,082.17 | 2019-2020 | |
| Saluda Medical Americas, INC. | $151.60 | 2024 | Evoke |
| Biedermann Motech, INC. | $88.63 | 2019 | |
| Nevro Corp. | $31.07 | 2024 | Senza |
| Painteq LLC | $26.97 | 2021 | |
| Medtronic, INC. | $25.88 | 2021 | |
| Nalu Medical, INC. | $25.00 | 2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $24.78 | 2023 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $16.80 | 2025 | |
| Becton, Dickinson and Company | $16.60 | 2025 | Surgiphor |
| Vertiflex, INC. | $14.63 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.30 | 2019 | |
| Si-Bone, INC. | $10.48 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$900,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Aryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.